The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Absolute risk reduction may depend on the duration of the follow-up
Open accessAbstract
Response to: Diamond DA and Ravnskov U. How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. Expert Rev Clin Pharm 2015;8(2):201-210.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
Hartmann, L. C., Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P. G., Petty, P. M., Sellers, T. A., Johnson, J. L., McDonnell, S. K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400201 · Cited by 1,428
Numbers needed to treat derived from meta-analyses---sometimes informative, usually misleading
Smeeth, L. L., Haines, A., & Ebrahim, S. B. J. (1999) · BMJ · doi:10.1136/bmj.318.7197.1548 · Cited by 299
Schechtman, E. (2002) · Value in Health · doi:10.1046/j.1524-4733.2002.55150.x · Cited by 216
Misleading communication of risk
Gigerenzer, G., Wegwarth, O., & Feufel, M. A. (2010) · BMJ · doi:10.1136/bmj.c4830 · Cited by 115
Diamond, D., & Ravnskov, U. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.1012494 · Cited by 75
Number needed to treat is a simple measure of treatment efficacy for clinicians
Rajkumar, S. V., Sampathkumar, P., & Gustafson, A. B. (1996) · Journal of General Internal Medicine · doi:10.1007/bf02600047 · Cited by 29
Primer: demystifying risk—understanding and communicating medical risks
Crowson, C. S., Therneau, T. M., Matteson, E. L., & Gabriel, S. E. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0397 · Cited by 20
Cited by
Sorted by citations
Efficacy and effectiveness of covid-19 vaccine - absolute vs. relative risk reduction
Marabotti, C. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2067531 · Cited by 13
“Actually, ARR and its derivative number needed to vaccinate to prevent a disease (NNV) are time-dependent parameters, affected by follow-up duration (Figure 1) [12].”
Background
Metadata
- Authors
- Ferenci, T.
- Affiliations
- Obuda University (HU)
- Corresponding author
- Ferenci, Tamás
- ORCID
- Ferenci, Tamás
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2015-11-02
- Volume
- 10
- Issue
- 12
- Pages
- 1409-1410
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- OpenAlex
- W1938345370
- Cited by
- 2
- References
- 8
- Citations by year
- 2022: 1 · 2019: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Expert Review of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- absolute risk reduction, follow-up duration, statins, cardiovascular disease prevention, primary prevention, secondary prevention, drug safety and efficacy
- MeSH terms
- Cardiovascular Diseases, Follow-Up Studies, Humans, Deception, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Secondary Prevention, Numbers Needed To Treat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Absolute risk reduction may depend on the duration of the follow-up. https://app.cochat.ai/papers/10.1586/17512433.2015.1102008
- The paper
- Ferenci, T. (2017). Absolute risk reduction may depend on the duration of the follow-up. Expert Review of Clinical Pharmacology. https://doi.org/10.1586/17512433.2015.1102008
